MedPath

Dose inidividualization of antimicrobials based on population pharmacokinetic analysis in patients undergoing blood purification therapy

Not Applicable
Conditions
sepsis
Registration Number
JPRN-UMIN000024321
Lead Sponsor
Kumamoto University Hospital
Brief Summary

In vancomycin-administered-patients with continuous blood purification therapy, we identified reduced urine output (RUO, <0.5 ml/kg/h) and effluent flow rate were the factor for the vancomycin clearance. Using the pharmacokinetic model, The compliance rate for therapeutic trough concentration by the Bayesian estimation was higher (87.0%) than that by a conventional method (53.8%, P = 0.046). The variance was lower (11.5) by the Bayesian estimation than by a conventional method (50.5, P = 0.003).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

In state with impossible sampling of blood for measurement of blood antimicrobial concentration

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath